In the all-too-common debate over building lab facilities versus outsourcing, the best strategy may be the middle ground: licensing.
Ravi Samavedam
Advertisement
Ravi Samavedam is chief innovation officer at Azzur Group.
Articles by Ravi Samavedam
Advertisement
Latest Updated Articles
Threading the Needle Between DIY and CDMONovember 15th 2022
Advertisement
Advertisement
Trending on BioPharm International
1
Alvotech, Advanz Submit First Eylea 8 mg Biosimilar Bid
2
Lilly's Mirikizumab (Omvoh) Hits New IBD Remission Goals
3
FDA Accepts BLA for Formycon and Zydus’ FYB206, the First Publicly Announced Keytruda Biosimilar Under Review
4
Shift to In Vivo CAR T Will Reshape Facility Design, Says Arcadis’ Emily Heffernan
5